Award-Pre-announcement for CCTS call for Pilot Applications; July 19, 2013

Pre-announcement for CCTS call for Pilot Applications

STAY TUNED! THE DETAILS OF EACH AWARD CATEGORY WILL BE RELEASED ON JULY 19, 2013

The Center for Clinical and Translational Science at UK will accept applications for pilot projects according to the following schedule:

v Call for Applications: July 19, 2013

v Letter of Intent due: August 16, 2013

v Invitation to submit Full Application: September 30, 2013

v Full Application due: November 1, 2013

v Funding Decision: January 2014

The categories of awards will be as follows:

PILOT AWARDS FOR JUNIOR INVESTIGATORS

This award is intended to support pilot studies by early stage investigators to obtain preliminary data for an eventual extramural grant submission.  The maximum award will be $25,000 which must be spent over 18 months.  This award is only open to investigators in the early stage of their career, or investigators who are transitioning into a new area. 

Full program details will be released on July 19, 2013 and available at http://www.ccts.uky.edu/Investigators/pilotstudy.aspx

Please note that the following new emphasis areas will be considered for this round of funding:

· Risk Related Behaviors with a focus on reducing the risk-related behaviors of obesity, tobacco, or substance abuse.

· Biomedical informatics collaborative projects.

· To support collaborations between basic scientists and clinician scientists and to promote clinicians scientists involvement in the proposed project,  a supplement of up to $25,000 for up to 10% effort may be requested for the clinician scientist.

PILOT INNOVATION & HIGH IMPACT AWARD FOR ALL INVESTIGATORS

This award is for investigators at all stages of career development, junior, middle level, and senior, and is intended to stimulate innovation and to support pilot studies that will lead to extramural funding.  The total award is limited to $50,000 which must be spent over 18 months. 

Full program details will be released on July 19, 2013 and available at http://www.ccts.uky.edu/Investigators/pilotstudy.aspx

Please note that the following new emphasis areas will be considered for this round of funding:

· Risk Related Behaviors with a focus on reducing the risk-related behaviors of obesity, tobacco, or substance abuse.

· Biomedical informatics collaborative projects.

· To support collaborations between basic scientists and clinician scientists and to promote clinicians scientists involvement in the proposed project, a supplement of up to $25,000 for up to 10% effort may be requested for the clinician scientist.

NOVEL METHODOLOGY

This award is intended to support new medical product development. Research teams submitting to this CCTS call for applications, typically would be preparing an SBIR or STTR proposal for NIH, often directed toward the National Institute for Biomedical Imaging and Bioengineering (NIBIB). The total award is $15,000, ideally for preparation of a proposal with a NIH SBIR deadline of Jan 2014.

Full program details will be released on July 19, 2013 and available at http://www.ccts.uky.edu/Investigators/pilotstudy.aspx

A list of SBIR announcements and an application guide are available:

http://grants.nih.gov/grants/funding/sbir_announcements.htm

http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_SBIR_STTR_Adobe_VerB.pdf

For questions, please contact Elodie Elayi at elodie.elayi@uky.edu

Elodie Elayi

Research Development Director

University of Kentucky

Center for Clinical and Translational Science

C300 AB Chandler Medical Center

800 Rose Street

Lexington, KY 40536-0293

Phone: 859.323.7939
Fax: 859.257.9560

Email: elodie.elayi@uky.edu

CCTS Investigators, please remember to acknowledge the NIH CTSA grant in your publications.

“This publication was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”